These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38830514)

  • 1. Evaluation methods using tear volume in a conjunctivitis mice model.
    Kai H; Haraoka N; Sugimoto Y
    J Pharmacol Toxicol Methods; 2024; 128():107520. PubMed ID: 38830514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of allergic conjunctivitis permitting tear eosinophil quantification.
    Ogura A; Sugimoto Y
    J Pharmacol Toxicol Methods; 2022; 118():107225. PubMed ID: 36130665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice.
    Hayat K; Asim MB; Nawaz M; Li M; Zhang L; Sun N
    Curr Eye Res; 2011 Jul; 36(7):591-8. PubMed ID: 21604966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
    Shii D; Nakagawa S; Shinomiya K; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Curr Eye Res; 2009 Jun; 34(6):426-37. PubMed ID: 19899977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of substance P in experimental allergic conjunctivitis in guinea pigs.
    Yamaji M; Takada M; Fujiwara R; Ohishi H; Izushi K; Sugimoto Y; Kamei C
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):637-43. PubMed ID: 9500128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models.
    Shii D; Nakagawa S; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Biol Pharm Bull; 2010; 33(8):1314-8. PubMed ID: 20686224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
    Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3: role in ocular allergy and potential as a predictive biomarker.
    Andrade FEC; Corrêa MP; Gimenes AD; Dos Santos MS; Campos M; Chammas R; Gomes JÁP; Gil CD
    Br J Ophthalmol; 2018 Jul; 102(7):1003-1010. PubMed ID: 29502069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
    Kato M; Imoto K; Miyake H; Oda T; Miyaji S; Nakamura M
    J Pharmacol Sci; 2004 Aug; 95(4):435-42. PubMed ID: 15286429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
    Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
    Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocabastine. Evaluation in the histamine and compound 48/80 models of ocular allergy in humans.
    Abelson MB; Smith LM
    Ophthalmology; 1988 Nov; 95(11):1494-7. PubMed ID: 3211458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
    Minami K; Hossen MA; Kamei C
    Biol Pharm Bull; 2005 Mar; 28(3):473-6. PubMed ID: 15744071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of lodoxamide.
    Leonardi AA; Smith LM; Fregona IA; Salmaso M; Secchi AG
    Eur J Ophthalmol; 1996; 6(2):106-12. PubMed ID: 8823580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated T cells in an animal model of allergic conjunctivitis.
    Carreras I; Carreras B; McGrath L; Rice A; Easty DL
    Br J Ophthalmol; 1993 Aug; 77(8):509-14. PubMed ID: 8025049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model.
    Barequet IS; Platner E; Sade K; Etkin S; Ziv H; Rosner M; Habot-Wilner Z
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1717-21. PubMed ID: 23553288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of allergic conjunctivitis by thermography.
    Hara Y; Shiraishi A; Yamaguchi M; Kawasaki S; Uno T; Ohashi Y
    Ophthalmic Res; 2014; 51(3):161-6. PubMed ID: 24603108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.